Publicaciones en las que colabora con Emma Recio (20)

2024

  1. Composición de la microbiota en pacientes con déficit de hormona de crecimiento antes y después de recibir tratamiento

    Anales de Pediatría: Publicación Oficial de la Asociación Española de Pediatría ( AEP ), Vol. 100, Núm. 6, pp. 404-411

2023

  1. Beyond the effects of HIV infection and integrase inhibitors-based therapies on oral bacteriome

    Scientific Reports, Vol. 13, Núm. 1

  2. Investigating the effects of moderate wine consumption on Alzheimer's disease in Aß- and Tau-pathology mice models

    BIO Web of Conferences

  3. Novel approach based on artificial intelligence to evaluate individual wine intake

    BIO Web of Conferences

2022

  1. IGF1R is a mediator of sex-specific metabolism in mice: Effects of age and high-fat diet

    Frontiers in Endocrinology, Vol. 13

  2. Impact of HIV infection and integrase strand transfer inhibitors-based treatment on the gut virome

    Scientific Reports, Vol. 12, Núm. 1

  3. Integrase Inhibitors Partially Restore Bacterial Translocation, Inflammation and Gut Permeability Induced by HIV Infection: Impact on Gut Microbiota

    Infectious Diseases and Therapy, Vol. 11, Núm. 4, pp. 1541-1557

2021

  1. ACE Gene Variants Rise the Risk of Severe COVID-19 in Patients With Hypertension, Dyslipidemia or Diabetes: A Spanish Pilot Study

    Frontiers in Endocrinology, Vol. 12

  2. Corrigendum: ACE Gene Variants Rise the Risk of Severe COVID-19 in Patients With Hypertension, Dyslipidemia or Diabetes: A Spanish Pilot Study (Frontiers in Endocrinology, (2021), 12, (688071), 10.3389/fendo.2021.688071)

    Frontiers in Endocrinology

  3. La investigación frente al SARS-COV-2 y la COVID-19 en el Departamento de Enfermedades Infecciosas del Hospital Universitario San Pedro-CIBIR

    Zubía, Núm. 39, pp. 63-73

2020

  1. Autologous fecal transplantation from a lean state potentiates caloric restriction effects on body weight and adiposity in obese mice

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. Characterization of gut microbiota composition in HIV-infected patients with metabolic syndrome

    Journal of Physiology and Biochemistry, Vol. 75, Núm. 3, pp. 299-309

  2. Short-term effects of direct-acting antiviral agents on inflammation and gut microbiota in hepatitis C-infected patients

    European Journal of Internal Medicine, Vol. 67, pp. 47-58

2018

  1. Agaricus bisporus supplementation reduces high-fat diet-induced body weight gain and fatty liver development

    Journal of Physiology and Biochemistry, Vol. 74, Núm. 4, pp. 635-646

2017

  1. Differential effects of antiretrovirals on microbial translocation and gut microbiota composition of HIV-infected patients

    Journal of the International AIDS Society, Vol. 20, Núm. 1

  2. Maraviroc ameliorates the increased adipose tissue macrophage recruitment induced by a high-fat diet in a mouse model of obesity

    Antiviral Therapy, Vol. 22, Núm. 2, pp. 163-168

2016

  1. Deciphering the molecular mechanisms involved in HIV-associated lipoatrophy by transcriptomics: a pilot study

    Journal of Physiology and Biochemistry, Vol. 73, Núm. 3, pp. 431-443

  2. Lack of adrenomedullin results in microbiota changes and aggravates azoxymethane and dextran sulfate sodium-induced colitis in mice

    Frontiers in Physiology, Vol. 7, Núm. NOV

2014

  1. Maraviroc, a CCR5 antagonist, ameliorates the development of hepatic steatosis in a mouse model of non-alcoholic fatty liver disease (NAFLD)

    Journal of Antimicrobial Chemotherapy, Vol. 69, Núm. 7, pp. 1903-1910

2012

  1. Investigación en VIH y Lipodistrofia en el Hospital San Pedro-Cibir: modelos "in vitro" de adipocitos para el estudio de los efectos tóxicos de fármacos antirretrovirales

    Zubía, Núm. 24, pp. 129